Effect of Green Tea Extract and Soy Isoflavones on the Pharmacokinetics of Rosuvastatin in Healthy Volunteers

被引:7
|
作者
Zeng, Weiwei [1 ]
Hu, Miao [2 ]
Lee, Hon Kit [3 ,4 ]
Wat, Elaine [5 ,6 ]
Lau, Clara Bik San [5 ,6 ]
Ho, Chung Shun [3 ]
Wong, Chun Kwok [3 ,5 ,6 ]
Tomlinson, Brian [2 ,7 ]
机构
[1] Jinan Univ, Shenzhen Baoan Womens & Childrens Hosp, Shenzhen, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med Therapeut, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Dept Chem Pathol, Hong Kong, Peoples R China
[4] Tuen Mun Hosp, Dept Clin Pathol, Hong Kong, Peoples R China
[5] Chinese Univ Hong Kong, Inst Chinese Med, Hong Kong, Peoples R China
[6] Chinese Univ Hong Kong, State Key Lab Res Bioactiv & Clin Applicat Med Pl, Hong Kong, Peoples R China
[7] Macau Univ Sci & Technol, Fac Med, Macau, Peoples R China
来源
FRONTIERS IN NUTRITION | 2022年 / 9卷
关键词
ABCG2; drug interaction; EGCG; green tea; rosuvastatin; soy isoflavones; DENSITY-LIPOPROTEIN CHOLESTEROL; HERB-DRUG INTERACTIONS; PLASMA-CONCENTRATIONS; SUPPLEMENTATION; TRANSPORTERS; EXPRESSION; STATINS; SLCO1B1; BCRP; (-)-EPIGALLOCATECHIN-3-GALLATE;
D O I
10.3389/fnut.2022.850318
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background and AimGreen tea and soy products are extensively consumed in daily life. Research has shown that green tea catechins and soy isoflavones may influence the activity of drug metabolizing enzymes and drug transporters. We examined whether regular consumption of green tea extract or soy isoflavones affected the pharmacokinetics of a single dose of rosuvastatin in healthy subjects and whether any interactions were influenced by the polymorphism in the drug transporter ABCG2. Study DesignThis was an open-label, three-phase randomized crossover study with single doses of rosuvastatin. MethodsHealthy Chinese male subjects were given a single dose of rosuvastatin 10 mg on 3 occasions: 1. without herbs; 2. with green tea extract; 3. with soy isoflavone extract. The green tea and soy isoflavone extract were given at a dose containing EGCG 800 mg once daily or soy isoflavones-80 mg once daily for 14 days before statin dosing and at the same time as the statin dosing with at least 4-weeks washout period between phases. ResultsTwenty healthy male subjects completed the study and the intake of green tea extract significantly reduced the systemic exposure to rosuvastatin by about 20% reducing AUC(0-24h) from [geometric mean (% coefficient of variation)] 108.7 (28.9) h center dot mu g/L to 74.1 (35.3) h center dot mu g/L and C-max from 13.1 (32.2) mu g/L to 7.9 (38.3) mu g/L (P < 0.001 for both), without affecting the elimination half-life. The ABCG2 421C>A polymorphism had a significant effect on rosuvastatin exposure but no impact on the interaction with green tea. Soy isoflavones had no significant effect on rosuvastatin pharmacokinetics. ConclusionThis study showed that repeated administration of green tea extract significantly reduced the systemic exposure of rosuvastatin in healthy volunteers. These effects might be predicted to either reduce or increase the lipid-lowering effect of rosuvastatin depending on the mechanism of the effect.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Effect of Clarithromycin on the Pharmacokinetics of Pranlukast in Healthy Volunteers
    Nakade, Susumu
    Yamauchi, Akinori
    Komaba, Junji
    Ohno, Tomoya
    Kitagawa, Junsaku
    Honda, Naoki
    Hasegawa, Chihiro
    Yoneda, Kazuhiro
    Kodama, Yasuo
    Yasuda, Kuninobu
    Azuma, Junichi
    Miyata, Yasuyuki
    DRUG METABOLISM AND PHARMACOKINETICS, 2008, 23 (06) : 428 - 433
  • [42] Effect of fluconazole on the pharmacokinetics of halofantrine in healthy volunteers
    Babalola, Chinedum P.
    Kolade, Yetunde T.
    Seriba, Gerhard K. E.
    Olaniyi, Ajibola A.
    Adedapo, Aduragba
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 535 - 535
  • [43] Effect of duloxetine on tolterodine pharmacokinetics in healthy volunteers
    Hua, TC
    Pan, A
    Chan, C
    Poo, YK
    Skinner, MH
    Knadler, MP
    Gonzales, CR
    Wise, SD
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (05) : 652 - 656
  • [44] Effect of fluconazole on the pharmacokinetics of halofantrine in healthy volunteers
    Babalola, C. P.
    Kolade, Y. T.
    Olaniyi, A. A.
    Adedapo, A.
    Scriba, G. K. E.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2009, 34 (06) : 677 - 682
  • [45] The effect of orlistat on the pharmacokinetics of phenytoin in healthy volunteers
    Melia, AT
    Mulligan, TE
    Zhi, JG
    JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (07): : 654 - 658
  • [46] Effect of ketoconazole on the pharmacokinetics of axitinib in healthy volunteers
    Pithavala, Yazdi K.
    Tong, Warren
    Mount, Janessa
    Rahavendran, Sadayappan V.
    Garrett, May
    Hee, Brian
    Selaru, Paulina
    Sarapa, Nenad
    Klamerus, Karen J.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (01) : 273 - 281
  • [47] Effect of age on clinafloxacin pharmacokinetics in healthy volunteers
    Randinitis, EJ
    Abel, R
    Bron, NJ
    Hounslow, NJ
    Rausch, G
    Vassos, AB
    DRUGS, 1999, 58 (Suppl 2) : 246 - 247
  • [48] The Effect of Rifampin on the Pharmacokinetics of Sofosbuvir in Healthy Volunteers
    Garrison, Kimberly L.
    Wang, Yi
    Brainard, Diana M.
    Sajwani, Karim
    Mathias, Anita
    HEPATOLOGY, 2014, 60 : 682A - 682A
  • [49] The Effect of Rifampin on the Pharmacokinetics of Sirolimus in Healthy Volunteers
    Tortorici, Michael A.
    Matschke, Kyle
    Korth-Bradley, Joan M.
    DiLea, Cliff
    Lasseter, Kenneth C.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (01): : 51 - 56
  • [50] Effect of Milk on the Pharmacokinetics of Oseltamivir in Healthy Volunteers
    Morimoto, Kaori
    Kishimura, Kozue
    Nagami, Takaaki
    Kodama, Nao
    Ogama, Yoichiro
    Yokoyama, Midori
    Toda, Shinya
    Chiyoda, Takeshi
    Shimada, Rieko
    Inano, Akihiro
    Kano, Takashi
    Tamai, Ikumi
    Ogihara, Takuo
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (09) : 3854 - 3861